If you buying after a 500% increase (see my recommendation of march 2008) you are buying even high risk.
Try not to forget the risks, if PPS is moving to the upside.
Expect the unexpected.
I will not invest at HEB in any kind in front of may 25, because I don´t think that Ampligen will be approved for treatment of CFS.
I think CFS is not a good target for this drug.
I read that in the past Ampligen has lifethreatening adverse effects. It was a 3 years old paper, but if there are life threatening events in the past in some kind, this drug will get no aproval for treatment of CFS.
LOL, go get them jj, give 'em hell. That scumbag macro told us we were all going to die of swine flu, scared the crap out of lots of nice folks. Then he basically admits it was all a pump job, says ampligen won't get approved, and runs off. What a major a-hole, huh?
I made my profits - and I am always avoiding risks which I can not control.
I repeat - there are reports in the past of life threatening events by the use of Ampligen and if this is true, there will no approval for a syndromal disorder like chronic fatigue syndrom, which isn´t well defined in the field of medicine and part of controversial discussion.
As I said CFS isn´t a good target for a approval. This disorder has many causes, if CFS is really existing.